dc.creatorWasowski, Cristina Lucia N.
dc.creatorLoscalzo, Leonardo Martin
dc.creatorHiggs, Josefina
dc.creatorMarder, Nora Mariel
dc.date.accessioned2017-06-14T19:43:06Z
dc.date.accessioned2018-11-06T11:57:52Z
dc.date.available2017-06-14T19:43:06Z
dc.date.available2018-11-06T11:57:52Z
dc.date.created2017-06-14T19:43:06Z
dc.date.issued2012-02
dc.identifierWasowski, Cristina Lucia N.; Loscalzo, Leonardo Martin; Higgs, Josefina; Marder, Nora Mariel; Chronic intraperitoneal and oral treatments with hesperidin induce central nervous system effects in mice; Wiley; Phytotherapy Research; 26; 2; 2-2012; 308-312
dc.identifier0951-418X
dc.identifierhttp://hdl.handle.net/11336/18196
dc.identifier1099-1573
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1861587
dc.description.abstractHesperidin (HN) is a flavanone glycoside abundantly found in citrus fruits. This flavonoid mediated central nervous system activity following intraperitoneal (i.p.) acute treatment. The responses of mice after the chronic i.p. (4 and 30 mg/kg/day) or the oral intake administration of this drug (20, 50 and 100 mg/kg/day) were studied by using the holeboard, the plus-maze and the locomotor activity tests. Hesperidin, chronically administered by the i.p. route, exerted a decrease in the locomotor and exploratory activities, thus evidencing a depressant activity. In turn, the chronic oral intake of this flavonoid induced anxiolytic-like effects. These varied responses could be attributed to the different routes of administration that could lead to the production of diverse active metabolites.
dc.languageeng
dc.publisherWiley
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1002/ptr.3560/abstract
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/ptr.3560
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHESPERIDIN
dc.subjectCENTRAL NERVOUS SYSTEM
dc.subjectDEPRESSANT ACTION
dc.subjectANXIOLYTIC ACTIVITY
dc.subjectINTRAPERITONEAL TREATMENT
dc.subjectORAL INTAKE
dc.titleChronic intraperitoneal and oral treatments with hesperidin induce central nervous system effects in mice
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución